BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22302005)

  • 1. Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells.
    Zhou J; Hu SE; Tan SH; Cao R; Chen Y; Xia D; Zhu X; Yang XF; Ong CN; Shen HM
    Autophagy; 2012 Mar; 8(3):338-49. PubMed ID: 22302005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin.
    Zhou J; Ong CN; Hur GM; Shen HM
    Biochem Pharmacol; 2010 May; 79(9):1242-50. PubMed ID: 20026083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andrographolide sensitizes the cytotoxicity of human colorectal carcinoma cells toward cisplatin via enhancing apoptosis pathways in vitro and in vivo.
    Lin HH; Shi MD; Tseng HC; Chen JH
    Toxicol Sci; 2014 May; 139(1):108-20. PubMed ID: 24563380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andrographolide induces autophagic cell death in human liver cancer cells through cyclophilin D-mediated mitochondrial permeability transition pore.
    Chen W; Feng L; Nie H; Zheng X
    Carcinogenesis; 2012 Nov; 33(11):2190-8. PubMed ID: 22869602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.
    Yang L; Wu D; Luo K; Wu S; Wu P
    Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proliferative and pro-apoptotic effects from sequenced combinations of andrographolide and cisplatin on ovarian cancer cell lines.
    Yunos NM; Mutalip SS; Jauri MH; Yu JQ; Huq F
    Anticancer Res; 2013 Oct; 33(10):4365-71. PubMed ID: 24123004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagic flux disruption contributes to Ganoderma lucidum polysaccharide-induced apoptosis in human colorectal cancer cells via MAPK/ERK activation.
    Pan H; Wang Y; Na K; Wang Y; Wang L; Li Z; Guo C; Guo D; Wang X
    Cell Death Dis; 2019 Jun; 10(6):456. PubMed ID: 31186406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation.
    Zhou J; Lu GD; Ong CS; Ong CN; Shen HM
    Mol Cancer Ther; 2008 Jul; 7(7):2170-80. PubMed ID: 18645026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway.
    Chen JH; Hsiao G; Lee AR; Wu CC; Yen MH
    Biochem Pharmacol; 2004 Apr; 67(7):1337-45. PubMed ID: 15013849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells.
    Zhou J; Zhang S; Ong CN; Shen HM
    Biochem Pharmacol; 2006 Jul; 72(2):132-44. PubMed ID: 16740251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint.
    Zheng K; Li Y; Wang S; Wang X; Liao C; Hu X; Fan L; Kang Q; Zeng Y; Wu X; Wu H; Zhang J; Wang Y; He Z
    Autophagy; 2016 Sep; 12(9):1593-613. PubMed ID: 27310928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells.
    Lin HH; Tsai CW; Chou FP; Wang CJ; Hsuan SW; Wang CK; Chen JH
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):336-45. PubMed ID: 21134392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andrographolide simultaneously augments Nrf2 antioxidant defense and facilitates autophagic flux blockade in cigarette smoke-exposed human bronchial epithelial cells.
    Tan WSD; Liao W; Peh HY; Vila M; Dong J; Shen HM; Wong WSF
    Toxicol Appl Pharmacol; 2018 Dec; 360():120-130. PubMed ID: 30291937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression.
    Shi MD; Lin HH; Chiang TA; Tsai LY; Tsai SM; Lee YC; Chen JH
    Chem Biol Interact; 2009 Aug; 180(3):344-52. PubMed ID: 19426720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A.
    Lu Y; Dong S; Hao B; Li C; Zhu K; Guo W; Wang Q; Cheung KH; Wong CW; Wu WT; Markus H; Yue J
    Autophagy; 2014; 10(11):1895-905. PubMed ID: 25483964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andrographolide causes p53-independent HCC cell death through p62 accumulation and impaired DNA damage repair.
    Li XY; Cui X; Xie CQ; Wu Y; Song T; He JD; Feng J; Cui QR; Bin JL; Li QY; Xiao C; Deng JH; Lu GD; Zhou J
    Phytomedicine; 2023 Dec; 121():155089. PubMed ID: 37738908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andrographolide inhibits human hepatoma-derived Hep3B cell growth through the activation of c-Jun N-terminal kinase.
    Ji L; Liu T; Liu J; Chen Y; Wang Z
    Planta Med; 2007 Oct; 73(13):1397-401. PubMed ID: 17918040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level.
    Zhao F; He EQ; Wang L; Liu K
    J Asian Nat Prod Res; 2008; 10(5-6):467-73. PubMed ID: 18464090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib exerts antitumor effects in HL-60 acute leukemia cells and inhibits autophagy by affecting lysosome function.
    Lu Y; Liu XF; Liu TR; Fan RF; Xu YC; Zhang XZ; Liu LL
    Biomed Pharmacother; 2016 Dec; 84():1551-1557. PubMed ID: 27884749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andrographolide enhances cisplatin-mediated anticancer effects in lung cancer cells through blockade of autophagy.
    Yuwen D; Mi S; Ma Y; Guo W; Xu Q; Shen Y; Shu Y
    Anticancer Drugs; 2017 Oct; 28(9):967-976. PubMed ID: 28692436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.